Europe PMC
open access
Engineered nanovaccines for prophylactic and therapeutic immunotherapy against cancer and infectious disease
Nanotechnology has transformed vaccine development by engineering nanovaccines that offer precise control over antigen performance, immune modulation and targeted delivery. These platforms influence physicochemical properties size, charge, and ligand expression to direct antigen trafficking, co-deli
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Targeted delivery platforms for in vivo immune cell engineering: emerging strategies for cancer immunotherapy.#1220890
- Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives.#242229
- Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives.#240444
- Progress in Protein Nanoparticle Vaccines for Human Viral Diseases.#455235
- Next-generation vaccine adjuvants: Integrating nanotechnology, systems immunology, and computational approaches for precision vaccinology#642691
Record · ID 1263668
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive